Search

Your search keyword '"Stevens VL"' showing total 286 results

Search Constraints

Start Over You searched for: Author "Stevens VL" Remove constraint Author: "Stevens VL"
286 results on '"Stevens VL"'

Search Results

1. Evaluation of pre-diagnostic blood protein measurements for predicting survival after lung cancer diagnosis.

2. Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3

3. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

4. Epidemiology of 40 blood biomarkers of one-carbon metabolism, vitamin status, inflammation, and renal and endothelial function among cancer-free older adults

5. Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

6. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.

7. Erratum to: Germline variation at 8q24 and prostate cancer risk in men of European ancestry (Nature Communications, (2018), 9, 1, (4616), 10.1038/s41467-018-06863-1)

8. Correction to: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (Nature Genetics, (2018), 50, 7, (928-936), 10.1038/s41588-018-0142-8)

9. Germline variation at 8q24 and prostate cancer risk in men of European ancestry (vol 9, 4616, 2018)

10. Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

11. Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia

12. Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia (vol 9, 1340, 2018)

13. Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma (vol 9, 3707, 2018)

14. Large-scale transcriptome-wide association study identifies new prostate cancer risk regions (vol 9, 4079, 2018)

15. Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility (vol 8, 1892, 2017)

16. Is high vitamin B12 status a cause of lung cancer?

17. Circulating markers of cellular immune activation in prediagnostic blood sample and lung cancer risk in the Lung Cancer Cohort Consortium (LC3)

18. Shared heritability and functional enrichment across six solid cancers

19. Association analyses identify 31 new risk loci for colorectal cancer susceptibility

20. Shared heritability and functional enrichment across six solid cancers (vol 10, 431, 2019)

21. Factors associated with oxidative stress and cancer risk in the Breast and Prostate Cancer Cohort Consortium

22. Circulating high sensitivity C reactive protein concentrations and lung cancer risk: a nested case-control study within the Lung Cancer Cohort Consortium

23. Germline variation at 8q24 and prostate cancer risk in men of European ancestry

24. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants

25. Impaired functional vitamin B6 status is associated with increased risk of lung cancer

26. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

27. Genome-wide association study identifies multiple risk loci for renal cell carcinoma

28. Discovery and fine-mapping of adiposity loci using high density imputation of genome-wide association studies in individuals of African ancestry: African ancestry anthropometry genetics consortium

29. Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation

30. Two susceptibility loci identified for prostate cancer aggressiveness

31. Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome

32. Associations between unprocessed red and processed meat, poultry, seafood and egg intake and the risk of prostate cancer: A pooled analysis of 15 prospective cohort studies

33. Genome-wide association study of renal cell carcinoma identifiestwo susceptibility loci on 2p21 and 11q13.3

34. Prostate cancer (PCa) risk variants and risk of fatal PCa in the national cancer institute breast and prostate cancer cohort consortium

35. Insulin-like growth factor pathway genes and blood concentrations, dietary protein, and risk of prostate cancer in the NCI breast and prostate cancer cohort consortium (BPC3)

36. N-acetyltransferase 2 polymorphisms, tobacco smoking, and breast cancer risk in the breast and prostate cancer cohort consortium

37. A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

38. Association between adult height, genetic susceptibility and risk of glioma

39. Detectable clonal mosaicism and its relationship to aging and cancer

40. Circulating 25-hydroxyvitamin D and risk of kidney cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

41. Correlates of circulating 25-hydroxyvitamin D: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

42. Circulating 25-hydroxyvitamin D and risk of non-Hodgkin lymphoma: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

43. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

44. Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium

45. Evaluation of pre-diagnostic blood protein measurements for predicting survival after lung cancer diagnosis.

46. Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population.

48. A cross-sectional study of inflammatory markers as determinants of circulating kynurenines in the Lung Cancer Cohort Consortium.

49. A prospective case-cohort analysis of plasma metabolites and breast cancer risk.

50. Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program.

Catalog

Books, media, physical & digital resources